NYSE: MRK

Explore the latest insights on NYSE: MRK and its impact on China’s pharmaceutical industry. Fineline Info & Tech delivers reliable data, news, and intelligence to help you navigate the complexities of NYSE: MRK’s developments with precision and clarity. Stay informed and enhance your decision-making at flcube.com.

METiS TechBio Partners with Eli Lilly on AI‑Driven Lipid Nanoparticle Delivery – Up to USD 1.1 Billion in Milestones for Tissue‑Specific LNP Discovery
CompanyDeals

METiS TechBio Partners with Eli Lilly on AI‑Driven Lipid Nanoparticle Delivery – Up to USD 1.1 Billion in Milestones for Tissue‑Specific LNP Discovery

METiS TechBio (HKG: 7666), an innovative AI drug delivery company, announced a strategic collaboration with Eli Lilly and Company (NYSE: LLY) focused on the research and discovery of novel lipid…

Sanofi Breaks Ground on Next‑Generation Insulin Manufacturing Facility at Frankfurt BioCampus – Full API Production Planned for 2032

Sanofi Breaks Ground on Next‑Generation Insulin Manufacturing Facility at Frankfurt BioCampus – Full API Production Planned for 2032

Hansoh Pharma Strikes Second ADC Licensing Deal with Roche – USD 400 Million Upfront, Over USD 15 Billion in Potential Milestones

Hansoh Pharma Strikes Second ADC Licensing Deal with Roche – USD 400 Million Upfront, Over USD 15 Billion in Potential Milestones

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
CompanyDrug

Merck’s Lagevrio Receives Emergency Conditional Approval from China’s NMPA

CompanyDeals

Sichuan Kelun Completes RMB 1.5 Billion Financing Round for Kelun-Biotech

CompanyDrug

Antengene and MSD Collaborate on Global Clinical Study for ATG-037

CompanyDeals

MSD and Kelun Biotech Ink Record-Breaking ADC Deal

CompanyDrug

Merck Launches Noxafil in China for Antifungal Treatment

CompanyDrug

Doer Bio and MSD Collaborate on Clinical Trial for Anti-Claudin18.2 Antibody DR30303

CompanyDeals

Merck Partners with Tsinghua Shenzhen for Organoid 3D Printing System

CompanyDrug

Merck’s Keytruda Receives 10th Indication Approval in China for TNBC

Show More